Skip to main content
. Author manuscript; available in PMC: 2022 Oct 27.
Published in final edited form as: JACC Cardiovasc Interv. 2020 Dec 14;13(23):2745–2752. doi: 10.1016/j.jcin.2020.09.059

TABLE 2.

Baseline Characteristics of Patients Who Underwent PFO Closure and Patients Who Received Medical Therapy

PFO Closure (n = 383) Medical Therapy (n = 208) p Value
Age, yrs 48.6 ± 12.1 53.2 ± 15.4 <0.001

Female 171 (44.6) 111 (53.4) 0.043

BMI, kg/m2 27.0 ± 7.7 27.0 ± 9.2 0.974

Medical history
 Hypertension 117 (30.5) 93 (44.7) 0.001
 Diabetes mellitus 23 (6.0) 29 (13.9) 0.001
 Hypercholesterolemia 134 (35.0) 90 (43.3) 0.047
 CAD history 12 (3.1) 20 (9.6) 0.001
 Smoking status
  Current 56 (14.6) 30 (14.4) 0.948
  Former 22 (5.7) 26 (12.5) 0.004
 Family history of stroke 83 (21.7) 36 (17.3) 0.206

Interatrial septal mobility
 Atrial septal aneurysm 82 (21.4) 23 (11.1) 0.002
 Hypermobility 70 (18.3) 30 (14.4) 0.233

Interatrial right-to-left shunt size
 Small 104 (27.2) 105 (50.5) <0.001
 Medium 98 (25.6) 38 (18.3) 0.044
 Large 181 (47.3) 65 (31.3) <0.001

Thrombophilia 89 (23.2) 45 (21.6) 0.657

Values are mean ± SD or n (%).

PFO = patent foramen ovale; other abbreviations as in Table 1.